{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T03:46:22.923384+00:00","published_at":"2026-10-16T13:53:08.730534+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:m3tr3k114o8t0","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:dylan-hartley-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:dd2ea82846845d6cfdd6eb3b994539b531b30e28f2744bafe014bece6451edc3"],"summary":"Dylan Hartley, Ph.D. executive of OnKure Therapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vl28dr1930ip9","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:isaac-manke-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:f68788d4654b5c6daf7b9852b3967e430fad467fa2caafd858ff238f11e825a0"],"summary":"Isaac Manke, Ph.D. executive of OnKure Therapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kvnv0svefjpq","event_type":"CFO_CHANGED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:jason-leverone-c-p-a","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:13bb82672cc44fe28c54d3261b34a0ca08354204a50ce8f92b9884913584a425"],"summary":"Jason Leverone, C.P.A. executive of OnKure Therapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11uloxfn72pxb","event_type":"CEO_CHANGED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:nicholas-a-saccomano-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:88ef8b79dde706af2fde2a3db25cb55a17bfe2a43119e4aeb844c6e16afbe7c0"],"summary":"Nicholas A. Saccomano, Ph.D. executive of OnKure Therapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1cn5rm61nlwg","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:samuel-agresta-m-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:1b68bd534e61a26ecfd0732cdddf8a578fbc118ec9e2aad8fbac023a111f92c8"],"summary":"Samuel Agresta, M.D. executive of OnKure Therapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1shzp9yyid0g0","event_type":"DIRECTOR_APPOINTED","effective_at":"2026-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:liam-ratcliffe-m-d-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Liam Ratcliffe, M.D., Ph.D. seat on OnKure Therapeutics, Inc., effective 2026-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:650q9t16on50v","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:andrew-phillips-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Andrew Phillips, Ph.D. seat on OnKure Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rlm4xnmm6nth","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:isaac-manke-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Isaac Manke, Ph.D. seat on OnKure Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1enbt6bdm4u3r","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:nicholas-a-saccomano-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Nicholas A. Saccomano, Ph.D. seat on OnKure Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:126sj0k1vws64a","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:r-michael-carruthers","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"R. Michael Carruthers seat on OnKure Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ssp71n1you8z5","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:valerie-m-jansen-m-d-ph-d","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Valerie M. Jansen, M.D., Ph.D. seat on OnKure Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:m198bf1i5nm1x","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:r-michael-carruthers","alpha:committee:onkure-therapeutics-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"R. Michael Carruthers member of Audit; Compensation, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:evxple1veax1g","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:edward-t-mathers","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Edward T. Mathers seat on OnKure Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cw14zfieyki7","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:michael-grey","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Michael Grey seat on OnKure Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2r9s521ok3wc4","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:committee:onkure-therapeutics-inc:audit-compensation","alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Audit; Compensation committee of OnKure Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y6rd5btgx3tb","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:53:08.730534+00:00","subject_ids":["alpha:person:edward-t-mathers","alpha:committee:onkure-therapeutics-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a"],"summary":"Edward T. Mathers member of Audit; Compensation, effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:5","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andrew-phillips-ph-d","object_label":"Andrew Phillips, Ph.D.","object_source_name_forms":[],"value":"Andrew Phillips, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andrew-phillips-ph-d","name":"Andrew Phillips, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:6","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:edward-t-mathers","object_label":"Edward T. Mathers","object_source_name_forms":[],"value":"Edward T. Mathers: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:edward-t-mathers","name":"Edward T. Mathers"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:7","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:isaac-manke-ph-d","object_label":"Isaac Manke, Ph.D.","object_source_name_forms":[],"value":"Isaac Manke, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:isaac-manke-ph-d","name":"Isaac Manke, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:8","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:liam-ratcliffe-m-d-ph-d","object_label":"Liam Ratcliffe, M.D., Ph.D.","object_source_name_forms":[],"value":"Liam Ratcliffe, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:liam-ratcliffe-m-d-ph-d","name":"Liam Ratcliffe, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2026-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2026-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:9","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-grey","object_label":"Michael Grey","object_source_name_forms":[],"value":"Michael Grey: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-grey","name":"Michael Grey"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:10","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nicholas-a-saccomano-ph-d","object_label":"Nicholas A. Saccomano, Ph.D.","object_source_name_forms":[],"value":"Nicholas A. Saccomano, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nicholas-a-saccomano-ph-d","name":"Nicholas A. Saccomano, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:11","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:r-michael-carruthers","object_label":"R. Michael Carruthers","object_source_name_forms":[],"value":"R. Michael Carruthers: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:r-michael-carruthers","name":"R. Michael Carruthers"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:12","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:valerie-m-jansen-m-d-ph-d","object_label":"Valerie M. Jansen, M.D., Ph.D.","object_source_name_forms":[],"value":"Valerie M. Jansen, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:valerie-m-jansen-m-d-ph-d","name":"Valerie M. Jansen, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:13","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:dylan-hartley-ph-d","object_label":"Dylan Hartley, Ph.D.","object_source_name_forms":[],"value":"Dylan Hartley, Ph.D.: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:dylan-hartley-ph-d","name":"Dylan Hartley, Ph.D."},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:dd2ea82846845d6cfdd6eb3b994539b531b30e28f2744bafe014bece6451edc3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:51.7866+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:14","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:isaac-manke-ph-d","object_label":"Isaac Manke, Ph.D.","object_source_name_forms":[],"value":"Isaac Manke, Ph.D.: Senior Vice President, Business Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:isaac-manke-ph-d","name":"Isaac Manke, Ph.D."},"title":"Senior Vice President, Business Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:f68788d4654b5c6daf7b9852b3967e430fad467fa2caafd858ff238f11e825a0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:52.161637+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:15","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jason-leverone-c-p-a","object_label":"Jason Leverone, C.P.A.","object_source_name_forms":[],"value":"Jason Leverone, C.P.A.: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jason-leverone-c-p-a","name":"Jason Leverone, C.P.A."},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:13bb82672cc44fe28c54d3261b34a0ca08354204a50ce8f92b9884913584a425","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:50.896804+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:16","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:nicholas-a-saccomano-ph-d","object_label":"Nicholas A. Saccomano, Ph.D.","object_source_name_forms":[],"value":"Nicholas A. Saccomano, Ph.D.: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:nicholas-a-saccomano-ph-d","name":"Nicholas A. Saccomano, Ph.D."},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:88ef8b79dde706af2fde2a3db25cb55a17bfe2a43119e4aeb844c6e16afbe7c0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:50.412483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1133e5d6-69fa-410a-a614-699caacd4bcc:leadership_role:17","subject_id":"alpha:company:1133e5d6-69fa-410a-a614-699caacd4bcc","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:samuel-agresta-m-d","object_label":"Samuel Agresta, M.D.","object_source_name_forms":[],"value":"Samuel Agresta, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:samuel-agresta-m-d","name":"Samuel Agresta, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:08.730534+00:00","sources":[{"id":"alpha:projection-evidence:document:1b68bd534e61a26ecfd0732cdddf8a578fbc118ec9e2aad8fbac023a111f92c8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:51.341523+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:b86e4d7058b26197e61111ef5a0da517688181e68ee708bb2d7e6db8ee10657a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"OnKure Therapeutics, Inc. DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000114036126015903/ny20066577x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:35:02.481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:dd2ea82846845d6cfdd6eb3b994539b531b30e28f2744bafe014bece6451edc3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:51.7866+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f68788d4654b5c6daf7b9852b3967e430fad467fa2caafd858ff238f11e825a0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:52.161637+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:13bb82672cc44fe28c54d3261b34a0ca08354204a50ce8f92b9884913584a425","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:50.896804+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:88ef8b79dde706af2fde2a3db25cb55a17bfe2a43119e4aeb844c6e16afbe7c0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:50.412483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1b68bd534e61a26ecfd0732cdddf8a578fbc118ec9e2aad8fbac023a111f92c8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"OKUR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312526104147/okur-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-16T06:23:51.341523+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.846,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.887,"cross_source_agreement":0.75,"temporal_completeness":0.765},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:08.730534+00:00","observed_at":"2026-10-16T13:53:08.730534+00:00","reviewed_at":"2026-10-16T13:53:08.730534+00:00","verified_at":"2026-10-16T13:53:08.730534+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/onkure-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/onkure-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}